Overview

Study of the Effects of XOMA 052 on Insulin Production in Subjects With Well Controlled Type 1 Diabetes

Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
The study hypothesis is that XOMA 052 may inhibit beta-cell destruction and enhance beta-cell regeneration. The purpose of this study is to assess the effects of XOMA 052 on beta-cell function and insulin production.
Phase:
Phase 2
Details
Lead Sponsor:
XOMA (US) LLC
Collaborator:
Juvenile Diabetes Research Foundation